載入...
Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated the efficacy and safety of irinotecan, 5-FU and a low dose of LV (modified FOLFIRI)...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Association of Internal Medicine
2005
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891154/ https://ncbi.nlm.nih.gov/pubmed/16295778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2005.20.3.205 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|